AIMC Topic: Neoplasms, Second Primary

Clear Filters Showing 11 to 17 of 17 articles

Deep Learning for Prediction of N2 Metastasis and Survival for Clinical Stage I Non-Small Cell Lung Cancer.

Radiology
Background Preoperative mediastinal staging is crucial for the optimal management of clinical stage I non-small cell lung cancer (NSCLC). Purpose To develop a deep learning signature for N2 metastasis prediction and prognosis stratification in clinic...

Breast Cancer Detection with Standalone AI versus Radiologist Interpretation of Unilateral Surveillance Mammography after Mastectomy.

Radiology
Background Limited data are available regarding the accuracy of artificial intelligence (AI) algorithms trained on bilateral mammograms for second breast cancer surveillance in patients with a personal history of breast cancer treated with unilateral...

Utilizing patient data: A tutorial on predicting second cancer with machine learning models.

Cancer medicine
BACKGROUND: The article explores the potential risk of secondary cancer (SC) due to radiation therapy (RT) and highlights the necessity for new modeling techniques to mitigate this risk.

Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia.

Blood
Although genomic alterations drive the pathogenesis of acute myeloid leukemia (AML), traditional classifications are largely based on morphology, and prototypic genetic founder lesions define only a small proportion of AML patients. The historical su...

Advanced Machine Learning in Prediction of Second Primary Cancer in Colorectal Cancer.

Studies in health technology and informatics
Colorectal cancer (CRC) ranked third among most commonly diagnosed cancers worldwide. The onset of second primary cancer (SPC) is an important indicator in treating CRC. We tried to use the advanced machine learning method in order to find the factor...

Robot-assisted Extracranial Stereotactic Radiotherapy of Adrenal Metastases in Oligometastatic Non-small Cell Lung Cancer.

Anticancer research
AIM: The aim of this study was to evaluate the efficacy and toxicity of stereotactic body radiation therapy (SBRT) in the treatment of patients with adrenal metastases in oligometastatic non-small-cell lung cancer (NSCLC).